ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Sign Up

Already a member? Sign in

Top Brokers

More Brokers

Market Data
News
Trading Tools
Markets
Discover

Hot Features

Follow Feed

Connect with traders and investors in our Follow Feed community.

Options Flow

Explore comprehensive options data and use advanced filters with Options Flow.

Monitor

Organize and monitor your stock and asset watchlist with Monitor.
Sign In Premium IconPremium Help Menu
FTSE 100
8,146.86
-0.21%
Dow Jones
38,589.16
-0.15%
Gold vs US Dollar
2,333.015
0.00%
Brent Oil
82.275
0.00%
Bitcoin
66,205.93
0.30%
Pepperstone
Advertisement
Registration Strip Icon for discussion Register to chat with like-minded investors on our interactive forums.
Get Started
  1. Home
  2. Investing
  3. Stocks
  4. USA
  5. NASDAQ

  6. Galapagos NV (GLPG) Share Price

GLPG Galapagos NV

25.75
0.03 (0.12%)
15 Jun 2024 - Closed
Delayed by 15 minutes
 Name  Symbol  Market  Type  ISIN  Description 
 Galapagos NV NASDAQ:GLPG NASDAQ Depository Receipt  Sponsored ADR
     Change  % Chg  Cur  Bid  Offer  High  Low  Open  Volume  Chg Time
Upgrade Icon
 		 RN  NRN 
   0.03 0.12 25.75 25.18 29.98 25.6125 25.315 25.37 132,414 04:00:04   
 Sector  Turnover  Profit  EPS - Basic  PE ratio  Mkt Cap 
 Coml Physical, Biologcl Resh 843.8M 211.7M 3.2125 7.41 1.57B
 Type  Size  Price  Time  Units 
 20 100 25.75 23:48:58 USD
 
Pre-Market and After-Hours
Recent News
DateTimeSource
HeadlineMore GLPG News
14/06/202421:01GLOBEGalapagos presents encouraging new data for CD19 CAR-T candidate GLPG5101 in non-Hodgkin lymphoma at EHA 2024
30/05/202421:44EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]
30/05/202421:01GLOBEGalapagos and Adaptimmune sign clinical collaboration agreement with an option to exclusively license Adaptimmune’s TCR T-cell therapy candidate, uza-cel, in head & neck cancer and potential future solid tumor indications
16/05/202421:28EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]
16/05/202421:01GLOBEGalapagos creates new subscription right plans
16/05/202413:11EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]
15/05/202421:01GLOBEGalapagos and Blood Centers of America announce strategic collaboration to accelerate Galapagos’ decentralized CAR-T manufacturing network in the U.S.
Period
Draw mode
Latest Message Board Discussions
DateTimeSource
Title
Posts
22/04/201315:57PBBGalapagos10
Data Downloads for GLPG

Export historical price information open, high, low, close, volume (OHLCV) to Excel

Intraday price data (2 weeks, 1 minute bars)


Loading Follow Feed...

Latest Galapagos NV Articles